Back to search

Peptide record

TPDB03942

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03942
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0 ToxinPred 3.0
standard
No
A 14-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
INLKAIAALAKKLL
Physicochemical Analysis
C70H130N18O16
RDCEQGHMFPSTWYV
AL
1479.91
10.84
3
0
10
+3
-0.15
1.157
195.71
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
1
Residue Composition
number
4
A
0
R
1
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
4
L
3
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 4 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
14
C70H130N18O16
1479.91
10.84
+3
-0.15
1.157
Evidence Records 68 records
Evidence 1 Activity

Activity

MIC
Antibacterial
25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 2 Activity

Activity

MIC
Antibacterial
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP DRAMP

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 3 Activity

Activity

MIC
Antibacterial
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP DRAMP

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 4 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP DRAMP

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 5 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP DRAMP

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 6 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP DRAMP

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 7 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP DRAMP

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 8 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP DRAMP

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 9 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP DRAMP

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 10 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP DRAMP

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 11 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 12 Activity

Activity

IC50
Antibacterial
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP DRAMP

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 13 Activity

Activity

IC50
Antibacterial
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP DRAMP

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 14 Activity

Activity

IC50
Antibacterial
5 µM

Target

P. pastoris

Source & Reference

dbAMP DRAMP

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 15 Activity

Activity

MIC
Antifungal
25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 16 Activity

Activity

MIC
Antifungal
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 17 Activity

Activity

MIC
Antifungal
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 18 Activity

Activity

MIC
Antifungal
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 19 Activity

Activity

MIC
Antifungal
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 20 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 21 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 22 Activity

Activity

MIC
Antifungal
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 23 Activity

Activity

MIC
Antifungal
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 24 Activity

Activity

MIC
Antifungal
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 25 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 26 Activity

Activity

IC50
Antifungal
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 27 Activity

Activity

IC50
Antifungal
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 28 Activity

Activity

IC50
Antifungal
5 µM

Target

P. pastoris

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 29 Activity

Activity

MIC
Antiparasitic
25 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 30 Activity

Activity

MIC
Antiparasitic
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP 3.0 DRAMP

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 31 Activity

Activity

MIC
Antiparasitic
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP 3.0 DRAMP

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 32 Activity

Activity

MIC
Antiparasitic
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP 3.0 DRAMP

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 33 Activity

Activity

MIC
Antiparasitic
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP 3.0 DRAMP

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 34 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP 3.0 DRAMP

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 35 Activity

Activity

MIC
Antiparasitic
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP 3.0 DRAMP

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 36 Activity

Activity

MIC
Antiparasitic
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP 3.0 DRAMP

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 37 Activity

Activity

MIC
Antiparasitic
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP 3.0 DRAMP

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 38 Activity

Activity

MIC
Antiparasitic
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP 3.0 DRAMP

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 39 Activity

Activity

MIC
Antiparasitic
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP 3.0 DRAMP

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 40 Activity

Activity

IC50
Antiparasitic
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP 3.0 DRAMP

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 41 Activity

Activity

IC50
Antiparasitic
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP 3.0 DRAMP

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 42 Activity

Activity

IC50
Antiparasitic
5 µM

Target

P. pastoris

Source & Reference

dbAMP 3.0 DRAMP

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 43 Activity

Activity

MIC
Antiviral
25 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 44 Activity

Activity

MIC
Antiviral
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 45 Activity

Activity

MIC
Antiviral
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 46 Activity

Activity

MIC
Antiviral
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 47 Activity

Activity

MIC
Antiviral
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 48 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 49 Activity

Activity

MIC
Antiviral
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 50 Activity

Activity

MIC
Antiviral
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 51 Activity

Activity

MIC
Antiviral
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 52 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 53 Activity

Activity

MIC
Antiviral
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 54 Activity

Activity

IC50
Antiviral
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 55 Activity

Activity

IC50
Antiviral
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 56 Activity

Activity

IC50
Antiviral
5 µM

Target

P. pastoris

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 57 Activity

Activity

82% degranulation
Toxicity
10 µg/mL
Cytotoxic
82% degranulation | 10 | µg/mL | target cell: Rat mast cells

Target

Rat mast cells

Source & Reference

NA
DBAASP
The mastoparanogen from wasp | Peptides | 2006
Evidence 58 Activity

Activity

0% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 32 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Evidence 59 Activity

Activity

3% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
3% Hemolysis | 64 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 60 Activity

Activity

10% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 128 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 61 Activity

Activity

26% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
26% Hemolysis | 256 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 62 Activity

Activity

0% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 64 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 63 Activity

Activity

5% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 64 Activity

Activity

23% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
23% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 65 Activity

Activity

50% Cell death
Toxicity
32 µg/mL
Cytotoxic
50% Cell death | 32 | µg/mL | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. | Chem Biol Drug Des | 2016
Evidence 66 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides from the venom gland of the social wasp Vespa tropica. | Toxicon | 2013
Evidence 67 Activity

Activity

50% Cell death
Toxicity
>67.6 µM
Cytotoxic
50% Cell death | >67.6 | µM | target cell: CEM-SS cells

Target

CEM-SS cells

Source & Reference

NA
DBAASP
Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database | Antimicrob Agents Chemother | 2010
Evidence 68 Activity

Activity

% Hemolysis
Toxicity
0 %
Hemolytic
Hemolytic_activity: [Ref.27591703] 0% hemolysis at 64 µg/ml against human red blood cells 0% hemolysis at 32 µg/ml , 6% hemolysis at 64 µg/ml against sheep red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochem Pharmacol. 2005 Jul 15 70(2):209-219. ##Chem Biol Drug Des. 2017 Mar 89(3):327-338. doi: 10.1111/cbdd.12864.